Phylabiotics
Phylabiotics's Overview
Phylabiotics is a clinical-stage biotechnology company at the forefront of microbiome research and development. We are committed to harnessing the power of the human microbiome to discover, develop, and commercialize novel therapies for a range of diseases. Our proprietary platform integrates computational biology, microbiology, and translational science to identify and advance promising candidates targeting areas such as the gut-brain axis, metabolic disorders, and inflammatory conditions.
Where is Phylabiotics's Headquarters?
HQ Function
Central hub for pioneering research in microbiome therapeutics, drug discovery, clinical development, and corporate operations.
Notable Features:
Advanced BSL-2 laboratories, cutting-edge genomics and metabolomics platforms, collaborative open-plan office spaces, and an on-site seminar room for scientific exchange.
Work Culture:
A science-driven, collaborative, and agile environment that encourages innovation, continuous learning, and a patient-centric approach. Emphasis on teamwork and cross-functional collaboration.
HQ Significance:
The heart of Phylabiotics's innovation engine, where groundbreaking discoveries in microbiome science are translated into potential new medicines for patients worldwide.
Values Reflected in HQ: The headquarters' design and resources reflect Phylabiotics's core values of scientific excellence, innovation, integrity, collaboration, and a steadfast commitment to patient impact.
Location:
Phylabiotics operates with a global mindset, supporting international research collaborations, managing multi-center clinical trials across different continents, and preparing for international regulatory submissions. Key functions supported globally include research partnerships, clinical operations, supply chain management for investigational products, and strategic business development to advance its therapeutic pipeline and ultimately reach patients worldwide.
Street Address:
123 BioDiscovery Drive
City:
Cambridge
State/Province:
MA
Country:
USA
Phylabiotics's Global Presence
Zurich, Switzerland
Address: Technoparkstrasse 1, 8005 Zürich
To spearhead Phylabiotics's clinical development programs in Europe, engage with key opinion leaders, and expand its presence within the European pharmaceutical and biotech landscape.
Buying Intent Signals for Phylabiotics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Phylabiotics
As of April 2025, Phylabiotics' leadership includes:
Investors of Phylabiotics
Phylabiotics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
No significant publicly announced executive hires or exits at Phylabiotics in the last 12 months. The leadership team remains stable, focused on advancing the company's strategic objectives and pipeline development.
Technology (Tech Stack) used by Phylabiotics
Discover the tools Phylabiotics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Phylabiotics Email Formats and Examples
Phylabiotics typically uses standard corporate email formats. The most common structure observed for companies of similar size and in the biotech sector is [first_initial][last_name]@[company_domain].com. For example, an employee named Jane Doe would likely have an email address such as jdoe@phylabiotics.com. Variations like [first_name].[last_name]@phylabiotics.com might also be in use.
[first_initial][last]@phylabiotics.com
Format
jdoe@phylabiotics.com
Example
85%
Success rate
News and media
BioPharma Wire • 2024-03-15
Phylabiotics Reports Positive Topline Data from Phase 1 Study of PHY-201 in Healthy Volunteers
Phylabiotics, a clinical-stage biotechnology company dedicated to microbiome therapeutics, today announced positive topline results from its Phase 1 clinical trial evaluating PHY-201, a novel orally administered microbiome therapeutic candidate. The randomized, double-blind, placebo-controlled study successfully met all primary safety and tolerability endpoints in healthy adult volunteers. The company reported that PHY-201 was well-tolerated with a favorable safety profile. Phylabiotics plans to present detailed findings at an upcoming scientific conference and initiate a Phase 2 proof-of-concept trial in patients with Irritable Bowel Syndrome (IBS) in late 2024....more
Global Biotech Bulletin • 2023-09-22
Phylabiotics Secures $25 Million in Series B Financing to Advance Microbiome Pipeline
Phylabiotics announced the successful closure of a $25 million Series B financing round. The funding was co-led by InnovateHealth Capital and Nexus Life Sciences Partners, with participation from existing investor BioFuture Ventures. The proceeds will be used to advance its lead candidate PHY-201 through Phase 2 clinical trials, expand its discovery platform, and strengthen its research and development team....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Phylabiotics, are just a search away.